Pancreatic Cancer

CECOG/PAN 1.3.001, SAKK 44/00

Breast Cancer

CECOG/BC.1.2.001

A phase II study evaluating the efficacy and safety of lapatinib + vinorelbine in ErbB2 positive metastatic breast cancer patients after progression of chemotherapy or hormonal treatment in combination with lapatinib for metastatic disease.

Status: recruitment finalized

CECOG/BC.1.3.005

A randomized phase III trial of Paclitaxel plus Bevacizumab versus Capecitabine plus Bevacizumab for the first line treatment of HER2-negative locally recurrent or metastatic breast cancer.

CECOG cooperates with the Spanish Breast Cancer Research Group (GEICAM) on this trial.

Status: Recruiting

Esophago-Gastric Cancer

CECOG/ESGAS 1.2.001

Phase II study of docetaxel in combination with oxaliplatin in patients with metastatic or locally recurrent esophagogastric cancer previously untreated with chemotherapy for advanced disease

Status: successfully closed after recruitment

CECOG/ESGAS 1.2.002

A Phase II Study of Irinotecan, mitomycin C and capecitabine as second line chemotherapy for patients with metastatic or locally recurrent esophago-gastric cancer previously treated with chemotherapy for advanced disease.

Gemcitabine and Cisplatin With and Without Subsequent Maintenance Therapy with Single Agent Gemcitabine in Stage IV Non-small Cell Lung Cancer. A Randomized, Multicentric Study (CECOG-NSCLC1)

CECOG/SPLENDOUR Trial

CECOG is proud to cooperate with the European Thoracic Oncology Platform (ETOP) on the trial “A randomized, open-label phase III trial evaluating the addition of denosumab to standard first-line anticancer treatment in advanced NSCLC”.

Prof. Zielinski on Clinical Trials

CECOG Contact Information

CECOG Mission

CECOG has been formed to unite centers of clinical oncology from Central- and Southeastern Europe as well as Israel into a body devoted to conducting clinical trials and providing postgraduate education in oncology.

We, the Scientific Board and the members of CECOG, want to design and conduct controlled clinical trials in clinical oncology according to guidelines defined by Good Clinical Practice, perform these trials meticulously and analyze their results with the utmost scientific care.

CECOG

If you have any questions please do not hesitate to contact us using the information provided below or the contact formular to the right.